(DRSK) Aptus Defined Risk - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US26922A3885
DRSK: Corporate Bonds, U.S. Stocks
The Aptus Defined Risk ETF (BATS:DRSK) is an actively managed exchange-traded fund that employs a hybrid strategy blending fixed income and equity investments. It allocates 75% to 95% of its assets to investment-grade corporate bonds, providing regular income and relatively lower risk. The remaining 5% to 25% is invested in U.S. equities, offering growth potential while incorporating risk management techniques to mitigate downside exposure.
With an average daily trading volume of 166,200 shares, the ETF offers moderate liquidity. Its last price of $27.47 aligns closely with its 20, 50, and 200-day simple moving averages, indicating price stability. The ATR of 0.26 reflects low volatility. As a short-term bond ETF with substantial assets under management of $1.13 billion, DRSK appeals to investors seeking a balance of income and growth with managed risk. The funds stable performance and low volatility suggest continued attractiveness for risk-averse investors in the near term.
Additional Sources for DRSK ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
DRSK ETF Overview
Market Cap in USD | 1,214m |
Category | Short-Term Bond |
TER | 0.78% |
IPO / Inception | 2018-08-07 |
DRSK ETF Ratings
Growth Rating | 20.4 |
Fundamental | - |
Dividend Rating | 33.5 |
Rel. Strength | 11.6 |
Analysts | - |
Fair Price Momentum | 26.84 USD |
Fair Price DCF | - |
DRSK Dividends
Dividend Yield 12m | 3.40% |
Yield on Cost 5y | 3.73% |
Annual Growth 5y | -11.50% |
Payout Consistency | 88.5% |
Payout Ratio | % |
DRSK Growth Ratios
Growth Correlation 3m | 1.5% |
Growth Correlation 12m | 55.4% |
Growth Correlation 5y | 10.1% |
CAGR 5y | 2.07% |
CAGR/Max DD 5y | 0.10 |
Sharpe Ratio 12m | -0.33 |
Alpha | 3.64 |
Beta | 0.157 |
Volatility | 8.18% |
Current Volume | 228k |
Average Volume 20d | 140.2k |
As of June 02, 2025, the stock is trading at USD 28.00 with a total of 228,017 shares traded.
Over the past week, the price has changed by -0.11%, over one month by +2.08%, over three months by +0.02% and over the past year by +9.12%.
Neither. Based on ValueRay´s Analyses, Aptus Defined Risk is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.38 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DRSK is around 26.84 USD . This means that DRSK is currently overvalued and has a potential downside of -4.14%.
Aptus Defined Risk has no consensus analysts rating.
According to our own proprietary Forecast Model, DRSK Aptus Defined Risk will be worth about 29.2 in June 2026. The stock is currently trading at 28.00. This means that the stock has a potential upside of +4.14%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.2 | 4.1% |